Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

97 results about "Bronchus" patented technology

A bronchus is a passage or airway in the respiratory system that conducts air into the lungs. The first bronchi to branch from the trachea are the right main bronchus and the left main bronchus, also known as the primary bronchi. These are the widest and enter the lungs at each hilum, where they branch into narrower secondary bronchi or lobar bronchi, and these branch into narrower tertiary bronchi or segmental bronchi. Further divisions of the segmental bronchi are known as 4th order, 5th order, and 6th order segmental bronchi, or grouped together as subsegmental bronchi. The bronchi when too narrow to be supported by cartilage are known as bronchioles. No gas exchange takes place in the bronchi.

Congestive obstruction pulmonary disease (COPD)

A method for treating Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis to alleviate the discomforts of breathing by using non-thermal electroporation energy to ablate diseased portions of the lung including the bronchus, airways and alveoli which, in effect, opens the restrictive diseased portions thereby maximizing the overall surface area thereof causing improved airflow and uninhibited breathing.
Owner:ANGIODYNAMICS INC

Methods, apparatuses, and systems for the treatment of pulmonary disorders

ActiveUS20250064510A1ElectrotherapySurgical instruments for heatingDiseaseAcute bronchitis
Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and / or other pulmonary diseases or disorders.
Owner:GALVANIZE THERAPEUTICS INC

Methods, apparatuses, and systems for the treatment of pulmonary disorders

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and / or other pulmonary diseases or disorders.
Owner:GALVANIZE THERAPEUTICS INC

Application of corynebacterium casei in preparation of medicine for preventing and treating lung injury

ActiveCN120131714AUnknown materialsRespiratory disorderTidal volumeCorynebacterium casei
The invention belongs to the technical field of biological medicine, and particularly relates to application of corynebacterium casei in preparation of medicine for preventing and treating lung injury. By constructing a radon inhalation-induced lung injury mouse model, after exposure at different radon levels, the weight of a mouse is reduced, the lung coefficient is increased, the tidal volume of the lung, the ventilation volume per minute and the maximum inspiration flow are reduced, the respiratory function is inhibited, the alveolar cavity of the mouse is abnormally expanded, the pulmonary septum is thickened and fractured, and more fibrin exudation is accompanied; the traditional Chinese medicine composition can be used for effectively inhibiting pulmonary fibrosis and lung injury due to obvious inflammatory infiltration beside bronchial tubes, extravasated blood in small blood vessels and lung tissue collagen deposition, and can be used for gavage of corynebacterium casei to effectively inhibit the above phenomena. Therefore, the corynebacterium casei can be used for preventing and treating lung injury, especially lung injury caused by radon exposure.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Construction method of lung drainage basin map

The invention discloses a lung drainage basin map construction method, which comprises the steps of obtaining point cloud data of bronchus, extracting a center line of the bronchus by using the point cloud data, and performing key point identification on the center line to obtain an undirected graph; firstly marking a main airway and first and second branches of the bronchial central line by using the undirected graph, and then marking the rest branches of the bronchial central line to obtain a marked bronchial central line; carrying out voxel distribution on the marked bronchial central line to obtain a first bronchial image; on the basis of the first bronchial image, a virtual branch is generated for the bronchial tube, and a second bronchial image is obtained; and calculating the average sectional area # imgabs0 # of each bronchus in the second bronchus image, calculating the weight # imgabs2 # of the bronchus in the lung drainage basin according to the average sectional area # imgabs1 #, and finally generating a lung drainage basin map in combination with the weight # imgabs3 #. The influence of bronchus thickness on the lung drainage basin is fully considered, and a more accurate lung drainage basin map can be generated.
Owner:CHONGQING FUDIMAI DIGITAL TECH CO LTD

Intelligent planning system for optimal path of natural orifice of pulmonary nodule

The invention relates to the field of medical image processing, in particular to a pulmonary nodule natural orifice optimal path intelligent planning system which comprises a data preprocessing module, a bronchus three-dimensional segmentation module, a pulmonary nodule segmentation module, a differential geometric path search module, a path evaluation module and a doctor interaction module. The differential geometric path search module comprises a Riemannian curvature flow modeling unit, a multi-scale Gaussian curvature constraint unit and a geodesic curvature self-adaptive correction unit, can model bronchus into a Riemannian manifold, applies curvature flow optimization, and combines a multi-scale decomposition strategy and a geodesic theory to obtain a geodesic curvature self-adaptive correction model; precise description and optimal path planning of bronchial geometrical characteristics are realized, the path evaluation module provides multi-dimensional evaluation of blood vessel avoidance, diameter adaptation and curvature safety, and the doctor interaction module supports three-dimensional visualization and real-time path editing. The problem that a traditional Euclidean space algorithm is insufficient in description of complex forms of bronchus is solved by introducing a differential geometry theory.
Owner:THE AFFILIATED HOSPITAL OF XUZHOU MEDICAL UNIV

Insertion part and endoscope

The invention provides an insertion part and an endoscope, relates to the technical field of endoscopes, and solves the problem of large displacement of the insertion part relative to a target focus due to respiratory movement in the prior art. The endoscope is provided with an insertion part, and a working channel, a first fluid channel and a second fluid channel which are mutually independent and extend from the near end to the far end are arranged in a front end assembly of the insertion part; a to-be-fixed area integrally adjacent to the front end assembly is arranged on the outer peripheral wall of the insertion part; the first fluid channel conveys the hydrogel to an outlet located in a to-be-fixed area to be discharged; the second fluid channel conveys the hydrogel degradation agent to an outlet located in a to-be-fixed area to be discharged; an outlet of the working channel is located in the far end face of the insertion part and used for instrument penetrating and negative pressure suction. The space between the insertion part and the bronchus can be filled with hydrogel through the first fluid channel so that the insertion part can be temporarily fixed to the position, adjacent to the focus, in the bronchus, and therefore the displacement degree between the insertion part and the focus can be reduced in the breathing process of a patient.
Owner:HUNAN HUAXIN MEDICAL TECHNOLOGY CO LTD

Application of Corynebacterium casei in preparation of medicine for preventing and treating lung injury

The present invention belongs to the field of biomedicine technology, and in particular to the application of Corynebacterium casei in the preparation of medicines for preventing and treating lung injury. The present invention constructs a mouse model of lung injury caused by radon inhalation and finds that after exposure to different radon levels, the mice lose weight, increase the lung coefficient, reduce the lung tidal volume, minute ventilation and maximum inspiratory flow, and their respiratory function is inhibited. The alveolar cavity of the mice is abnormally expanded, the lung septum is thickened and fractured, accompanied by more fibrin exudation, obvious inflammatory infiltration appears near the bronchus, congestion occurs in small blood vessels, and collagen deposition in lung tissue can lead to the occurrence of pulmonary fibrosis, causing lung injury. Oral administration of Corynebacterium casei can effectively inhibit the above-mentioned phenomenon. Therefore, Corynebacterium casei can be used for the prevention and treatment of lung injury, especially lung injury caused by radon exposure.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Inhaled respiratory probiotics for lung diseases of infancy, childhood and adulthood

The respiratory microbiomes of neonates and those with bronchopulmonary disease have been characterized. Provided are probiotic compositions, which can include at least one living bacterial strain and at least one killed bacterial strain, that can comprise a combination of Lactobacilli species, that when delivered to the bronchi or lungs of a patient can provide a reduction in the symptoms of a bronchopulmonary disease.
Owner:THE UAB RESEARCH FOUNDATION INC

High-potency biased beta-2 adrenergic receptor agonist for treating respiratory diseases

Respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) are commonly treated with β2-adrenergic receptor agonists that activate intracellular signaling pathways to induce airway relaxation. However, current therapies are limited by progressive receptor desensitization, or tachyphylaxis, largely attributed to β-arrestin recruitment. This desensitization reduces therapeutic efficacy over time and complicates long-term disease management, resulting in suboptimal outcomes for patients who rely on bronchodilators for daily symptom control. Disclosed herein are pharmaceutical compositions comprising biased agonists and their methods of use, which minimally activate recruitment of beta-arrestin2.
Owner:UNIV OF SOUTH FLORIDA

Segmentation modeling method for improving bronchial branch identification precision

The invention discloses a segmentation modeling method for improving bronchial branch identification precision, and belongs to the technical field of medical image processing and respiratory tract three-dimensional reconstruction. According to the method, high-resolution acquisition is performed on a respiratory tract CT image, and preliminary segmentation of a tracheal tree is completed in combination with gray threshold setting and a region growing algorithm; and a reference line is introduced at the bifurcation, and dynamic region growth based on density gradient is adopted, so that refined identification of the sixth-level bronchial branch is realized. And then carrying out iteration correction on the generated model for multiple times, manually comparing anatomical features to delete pseudo branches and complement missing branches, and completing smoothing and NURBS curved surface construction in Geomagic software. And finally, splicing and fusing the bronchial branch model and an independently generated upper respiratory tract model to obtain a complete three-dimensional respiratory tract combination model, and ensuring that the error between the three-dimensional respiratory tract combination model and an original CT image is controlled within 0.8 mm through deviation analysis. According to the method, the recognition precision of the fine bronchial branches can be remarkably improved, the defect of misrecognition or missing division of traditional threshold segmentation is overcome, and the obtained three-dimensional model can be used for aerosol drug deposition simulation, respiratory system disease diagnosis, surgical planning and design and evaluation of personalized inhalation devices.
Owner:HUAZHONG UNIV OF SCI & TECH

A nitrile derivative as a dipeptidyl peptidase 1 inhibitor and its use

Provided is a nitrile derivative compound represented by formula (I), its stereoisomers, deuterated compounds, cocrystals, solvates or pharmaceutically acceptable salts, with each group as defined in the specification. The compound has dipeptidyl peptidase 1 inhibitory activity and can be used for preparing drugs for treating diseases including airway obstructive diseases, bronchodilation, cystic fibrosis, asthma, emphysema and chronic obstructive pulmonary disease, etc.
Owner:HAISCO PHARMACEUTICAL GROUP CO LTD

Bronchial lung irrigation solution composition for treating non-small cell lung cancer and preparation method thereof

The invention discloses a broncholung lavage fluid composition for treating non-small cell lung cancer, and relates to the technical field of cancer treatment. The preparation method of the bronchus lung lavage fluid composition for treating the non-small cell lung cancer comprises the following steps: S1, performing metagenome sequencing on a BALF sample, S2, grouping by R / NR based on differential strains obtained in S1 to obtain core bacteria, performing single-strain Kaplan-Meier survival analysis on the strains, and determining the survival rate of the single-strain Kaplan-Meier to obtain the bronchus lung lavage fluid composition for treating the non-small cell lung cancer. Finally, seven key microorganisms, namely bronchopulmonary lavage fluid combinations, which are remarkably related to immunotherapy PFS are locked; s3, determining the relationship between the seven key BALF bacteria and the existing immune therapeutic effect marker; and S4, verifying the generation conditions of IL6, IL8 and RANTES cytokines promoted by the seven strains through an in-vitro cell experiment, and revealing the activation and enhancement effects of the seven strains on immune cell functions. According to the invention, the immunotherapy effect of the non-small cell lung cancer patient can be promoted to be improved by combining a plurality of beneficial specific microorganisms in an airway administration mode. In conclusion, the method has a good application prospect.
Owner:GUANGDONG GENERAL HOSPITAL

Lung segment bronchial catheter

The application provides a lung segment bronchus catheter, which comprises a catheter tail end ventilation and suction interface, a cuff inflation device, an outer tube, an inner tube, a front end cuff and a guide end formed by the inner tube; the cuff is annularly arranged on the outer surface of the catheter head, and is in the form of a ring ball wrapped around the inner tube in the inflated state; the cuff inflation interface and the cuff inflation conduit are communicated between the gap between the outer tube and the inner tube at the catheter tail and lead to the cuff; the catheter ventilation and suction interface is communicated with the inner tube and the guide end formed by the inner tube, and a guide wire is arranged in the catheter ventilation and suction interface to form a straight lumen. The catheter can enter the target lung segment or sub-lung segment bronchus through the operation channel of the bronchoscope, the inflated cuff seals the airway cavity around the lung segment bronchus catheter cavity, then the guide wire is pulled out from the lung segment bronchus catheter cavity, the target lung segment or sub-lung segment is inflated through the catheter ventilation and suction interface, so that the anatomical range of the target lung segment or sub-lung segment after ventilation is revealed, the technical problem that a thoracic surgeon cannot accurately identify the anatomical range of the target lung segment in the operation is effectively solved, and the thoracic surgery anatomical partial lobectomy operation is facilitated.
Owner:CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI

Method for diagnosing acute exacerbation of bronchiectasis and kit therefor

The present invention relates to a method for predicting acute exacerbation of bronchiectasis, and a kit therefor. When the method and the kit according to the present invention are used, acute exacerbation of bronchiectasis can be easily diagnosed through a quantitative index.
Owner:Z BIOTECH INC

Lung segment bronchus plugging assembly

ActiveCN222487492USurgeryMedical equipmentSegmental pulmonary vein
The utility model discloses a pulmonary segment bronchus plugging assembly, which relates to the technical field of medical equipment and comprises a tube body and a cuff embedded in the outer wall of the far end of the tube body, the cuff is communicated with an opening of the far end of the tube body, a plurality of first developing parts are arranged on the inner wall of the cuff and are uniformly arranged at intervals in an annular structure, and a plurality of second developing parts are arranged on the outer wall of the cuff. The first developing part displays the inflation expansion deformation quantity of the cuff under CT scanning. The tube body is used for assisting in observing and guiding the cuff to selectively enter a target lung segment cavity opening, then the near-end connector of the tube body is inflated, the cuff is expanded after being inflated, the size of the cuff is increased, under CT scanning, the images that the first developing parts move away from one another along with the expanded and deformed cuff are displayed, medical staff know the expanded and deformed amount of the cuff in real time, and the medical staff can know the expanded and deformed amount of the cuff in real time. The outer wall of the cuff is tightly attached to the inner wall of the target lung segment tissue, the boundary of the inflated lung tissue and the non-inflated lung tissue is an inter-segment plane, the lesion position can be diagnosed conveniently, and meanwhile the situation that the target lung segment tissue is damaged easily due to excessive expansion of the cuff is avoided.
Owner:NANJING DRUM TOWER HOSPITAL +1

Adeno-associated virus vector capable of specific gene delivery to the lung

The present invention provides a mutant adeno-associated virus serotype 1 (AAV1) capsid protein, wherein the mutant has an amino acid substitution at a specific position compared to the amino acid sequence of the wild-type AAV capsid protein; a nucleic acid encoding the mutant AAV1 capsid protein; a recombinant AAV1 vector comprising the nucleic acid encoding the mutant AAV1 capsid protein; and a pharmaceutical composition comprising the vector. In particular, a recombinant viral vector comprising the nucleic acid encoding the mutant AAV1 capsid protein enhances transgene expression in the lungs and bronchi when delivered in an aerosol state through the bronchi, making it useful for the prevention or treatment of respiratory diseases.
Owner:GLUGENETHERAPEUTICS INC

Inhalable bronchodilator sustained release compositions for the treatment of pulmonary disorders

This invention provides a liposomal sustained-release composition of a bronchodilator for treating lung diseases. The liposomal bronchodilator comprises liposomes encapsulating the bronchodilator. The bronchodilator is stably encapsulated in the liposomes, and the resulting liposomal bronchodilator has been shown to be stably nebulized or aerosolized for administration via inhalation to treat individuals in need.
Owner:YINGBO BIOTECHNOLOGY CO LTD

Melamine pulse intermittent purging and separating device

The utility model relates to a melamine pulse batch-type purging separation device, the output end is connected with a pipeline system, the device comprises a branch air pipe, a flow deflector is arranged at the connecting position of the pipeline system and the branch air pipe, the flow deflector wraps the outlet of the branch air pipe and forms a flow guide cavity, the flow deflector comprises an arc-shaped part and a straight line part, and the arc-shaped part is connected with the straight line part. And the straight line part is parallel to the flow direction of gas in the pipeline system. According to the utility model, the valve is intermittently purged through the branch air pipe pulse, so that the interior of the valve body is ensured to be clean, and the valve acts freely and is closed tightly; meanwhile, the flow deflectors are arranged, the flow direction of gas can be changed, the gas is forced to be parallel to the linear part, and therefore the gas flowing out of the branch gas pipes and the gas flow direction in the pipeline system are the same, and the pulse effect of compressed gas can be reserved.
Owner:ANHUI HUAERTAI CHEM IND

Preparation method of respiratory tract delivery preparation for severe respiratory system diseases

The invention discloses a preparation method of a respiratory tract delivery preparation for severe respiratory system diseases, the respiratory tract delivery preparation comprises the following components by weight: 2 * 10 < 8 >-2 * 10 < 9 > pieces / ml of cell exosomes, normal saline with atomization concentration of 3%, and the balance of water. The cell exosome is composed of adipose-derived stem cell exosomes and bone marrow stem cell exosomes, the adipose-derived stem cell exosomes are 1 * 10 < 8 >-1 * 10 < 9 > / ml, the bone marrow stem cell exosomes are 1 * 10 < 8 >-1 * 10 < 9 > / ml, and the ratio of the adipose-derived stem cell exosomes to the bone marrow stem cell exosomes is 1: 1. The respiratory tract delivery preparation prepared by the invention can utilize nasal spray, aerosol inhalation or other suitable drug delivery technology, and the drug delivery method ensures that the preparation directly enters the respiratory system, nasal mucosa and bronchoalveolus, which generally relieves the curative effect of treating major respiratory system diseases at present. And a clinical basis is provided for research and development in a new direction of disease-targeted biological treatment.
Owner:SHANDONG YIXIN MEDICAL TECHNOLOGY CO LTD

Treatment of non-cystic fibrosis bronchiectasis (NCFB)

PCT designated stageWO2026133299A1Pharmaceutical delivery mechanismCyclic peptide ingredientsColistimethate SodiumInhalation
Described is a method for improving the condition of a patient suffering from Non-Cystic Fibrosis Bronchiectasis (NCFB), comprising administering to the patient by inhalation from 2.5 million international units (MIU) to 6 MIU of colistimethate sodium (CMS) once a day for a period of at least 28 days. Other embodiments are also disclosed.
Owner:SPEXIS AUSTRALIA PTY LTD

Protective mask for tracheotomy sputum suction

The protective mask comprises a mask body and an upper mask body, the upper mask body is arranged at the top of the mask body, the surface of the mask body is fixedly connected with reinforcing ribs, the inner wall of the mask body is connected with the mask body through springs, the mask body is attached to the edge of a breathing mask, and the breathing mask is fixedly connected with a connecting strip through a side strip. The upper cover body is fixedly connected with the frame body, and a lens is fixedly connected in the frame body. Connection of the breathing mask can be achieved by arranging the mask body, the mask body can protect the mouth and the nose of a doctor, the breathing mask is limited through the adjustable side edge strips and the connecting strips, the edge of the breathing mask is pressed and fixed by arranging the mask body, eye protection can be achieved by arranging the movable upper mask body, and the breathing mask is convenient to use. The eyes of a doctor can be tightly attached to the buffer ring, the eye protection effect is guaranteed, meanwhile, the upper cover body is stably fixed, the lens is arranged in the frame body, observation of the doctor can be facilitated, and smooth operation is achieved.
Owner:GUANYUN COUNTY PEOPLES HOSPITAL

Application of Sweeping mahonia lung-heat-clearing cough-relieving composition in treatment of chronic obstructive pulmonary disease

PendingCN121987690ASuppress abnormal reconstructionImprove pharmacological activityAntipyreticAnalgesicsApoptosisObstructive Pulmonary Diseases
The invention relates to the field of traditional Chinese medicines, in particular to novel application of a Sweeping Tianhu lung-clearing and cough-relieving composition in treatment of chronic obstructive pulmonary disease. Animal experiment studies show that the Sweetio lung-clearing and cough-relieving composition can significantly improve the lung function of COPD mice and inhibit bronchial abnormal remodeling. The action mechanism of the composition is related to inhibition of lung tissue cell apoptosis, alleviation of inflammatory cell infiltration and improvement of abnormal remodeling of bronchus, which indicates that the Sweeping Litu composition for clearing away lung-heat and relieving cough has obvious pharmacological activity of resisting COPD (chronic obstructive pulmonary disease).
Owner:INNER MONGOLIA TIANQI HAN&MONGOLIA PHARMA CO

Inhaler system

ActiveUS12779148B2DiseaseCopd exacerbation
Provided is a system (10) for determining a probability of a CORD exacerbation in a subject. The system comprises a first inhaler (100) for delivering a rescue medicament to the subject. The rescue medicament may be suitable for treating the subject's acute respiratory disease, for example by effecting rapid dilation of the bronchi and bronchioles upon inhalation of the medicament. The first inhaler has a use-detection system (12B) configured to determine a rescue inhalation performed by the subject using the first inhaler. The system optionally includes a second inhaler for delivering a maintenance medicament to the subject during a routine inhalation A sensor system (12A) is configured to measure a parameter relating to airflow during the rescue inhalation and / or during the routine inhalation, when the second inhaler is included in the system. The system further comprises a processor (14) configured to determine a number of the rescue inhalations during a first time period, and receive the parameter measured for at least some of the rescue and / or routine inhalations. The processor then determines, using a weighted model, the probability of the CORD exacerbation based on the number of rescue inhalations and the parameters. The model is weighted such that the parameters are more significant in the probability determination than the number of rescue inhalations. Further provided is a method for determining the probability of a COPD exacerbation in a subject, which method employs the weighted model.
Owner:NORTON (WATERFORD) LTD

Compositions and methods for treating and ameliorating respiratory conditions and inflammation of mucosa

Disclosed are compositions and methods for treating, amelioriating, reversing and / or preventing (acting as a prophylaxis): a respiratory condition involving an infection or an inflammation, or any lung condition involving inflammation or infection, e.g., of a respiratory mucosa, and / or an infection or an inflammation of an underlying muscle of the respiratory tract; or, an asthma; a bronchitis; a sinusitis or rhinosinusitis; an infection of a sinus; chronic obstructive airway disease; emphysema; chronic bronchitis; pneumonia; or, a bronchiectasis. In alternative embodiments, the therapeutic combination comprises an orally administered Amphotericin B or equivalent antifungal alone, or a combination of Amphotericin B and: one antibiotic; two antibiotics; three antibiotics; or, four or more antibiotics. In alternative embodiments, these compositions and methods are dosaged and administered to children in need thereof. In alternative embodiments, compositions and methods of the invention are dosaged, formulated and dosaged as tablet, capsule, liquid, powder or aerosol preparations or formulations, or preparations or formulations for oral delivery or inhalation.
Owner:ATOPIC MEDICAL INC

Implantable artificial bronchus and use of an implantable artificial bronchus

An implantable artificial bronchus (IAB) is provided that is used for the treatment of chronic obstructive pulmonary diseases, such as pulmonary emphysema. The implantable artificial bronchus can be made with silicone or nitinol, and has a tapered cylindrical shape. Additional embodiments of this apparatus may be further associated with a one-way valve on the nozzle of the IAB.
Owner:PULMAIR MEDICAL INC